NCT07446257 2026-03-03
THIO and Cadonilimab in Resectable Hepatocellular Carcinoma
University of Texas Southwestern Medical Center
Phase EARLY_PHASE1 Not yet recruiting
Clinical Trials
7 trialsNCT06653023 2026-01-20
Wondercel-UWD3
Wondercel Biotech (ShenZhen)
Phase EARLY_PHASE1 Recruiting
NCT07295262 2025-12-19
NIR-II Fluorescence-Guided Hepatectomy Using ICG-Cisplatin Nanoprobes for HCC
West China Hospital
Phase EARLY_PHASE1 Recruiting
NCT04857684 2025-10-01
SBRT + Atezolizumab + Bevacizumab in Resectable HCC
Massachusetts General Hospital
Phase EARLY_PHASE1 Active not recruiting
NCT06383520 2025-05-14
Study on the Clinical Application Value of PET Imaging Targeting GPC3 in Hepatocellular Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1 Recruiting
NCT06092112 2025-04-24
A Clinical Trial for the Safety and Efficacy of CD-801 in Patients With Advanced Hepatocellular Carcinoma
Shanghai Changzheng Hospital
Phase EARLY_PHASE1 Completed
NCT06418659 2025-04-24
A Clinical Trial Evaluating the Safety and Efficacy of Intravenous CD-801 in Treating Advanced HCC Patients
Shanghai Changzheng Hospital
Phase EARLY_PHASE1 Recruiting